» Articles » PMID: 39090741

Neuroimmune Modulation in Liver Pathophysiology

Overview
Publisher Biomed Central
Date 2024 Aug 1
PMID 39090741
Authors
Affiliations
Soon will be listed here.
Abstract

The liver, the largest organ in the human body, plays a multifaceted role in digestion, coagulation, synthesis, metabolism, detoxification, and immune defense. Changes in liver function often coincide with disruptions in both the central and peripheral nervous systems. The intricate interplay between the nervous and immune systems is vital for maintaining tissue balance and combating diseases. Signaling molecules and pathways, including cytokines, inflammatory mediators, neuropeptides, neurotransmitters, chemoreceptors, and neural pathways, facilitate this complex communication. They establish feedback loops among diverse immune cell populations and the central, peripheral, sympathetic, parasympathetic, and enteric nervous systems within the liver. In this concise review, we provide an overview of the structural and compositional aspects of the hepatic neural and immune systems. We further explore the molecular mechanisms and pathways that govern neuroimmune communication, highlighting their significance in liver pathology. Finally, we summarize the current clinical implications of therapeutic approaches targeting neuroimmune interactions and present prospects for future research in this area.

References
1.
Churchland P, Winkielman P . Modulating social behavior with oxytocin: how does it work? What does it mean?. Horm Behav. 2011; 61(3):392-9. PMC: 3312973. DOI: 10.1016/j.yhbeh.2011.12.003. View

2.
Reardon C, Murray K, Lomax A . Neuroimmune Communication in Health and Disease. Physiol Rev. 2018; 98(4):2287-2316. PMC: 6170975. DOI: 10.1152/physrev.00035.2017. View

3.
Zemtsova I, Gorg B, Keitel V, Bidmon H, Schror K, Haussinger D . Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011; 54(1):204-15. DOI: 10.1002/hep.24326. View

4.
Smith G, Jerome C, Cushin B, Eterno R, Simansky K . Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science. 1981; 213(4511):1036-7. DOI: 10.1126/science.7268408. View

5.
Weinstein A, Diao G, Baghi H, Escheik C, Gerber L, Younossi Z . Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis. Qual Life Res. 2017; 26(7):1777-1784. DOI: 10.1007/s11136-017-1516-6. View